Fifth Lane Capital’s Avidity Biosciences RNAM Stock Holding History

Fifth Lane Capital’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-46,300	Closed	-$3.34M	–	113
2025 Q4	$3.34M	Buy	+46,300	New	+$2.99M	2.53%	10

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $206M AUM 26.42% 1-Year Est. Return

Fifth Lane Capital's RNAM Position: Q1 2026 in Review

Fifth Lane Capital sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 61,000 shares — an estimated $4.4M sold.

Fifth Lane Capital first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $4.4M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Fifth Lane Capital reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Fifth Lane Capital sold 61,000 Avidity Biosciences shares in Q1 2026, an estimated $4.4M.
Fifth Lane Capital first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
Fifth Lane Capital's Avidity Biosciences position peaked at $4.4M in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Fifth Lane Capital's 13F filing for Q1 2026, filed 15 May 2026.